Piramal Pharma Limited (PPLPHARMA.BO)
INR 219.65
(5.45%)
INR 219.65
(5.45%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 24.83 Billion INR | -28.74% |
| 2022 | 34.85 Billion INR | 28.69% |
| 2021 | 27.08 Billion INR | 36648.17% |
| 2020 | 73.7 Million INR | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 15.35 Billion INR | 0.0% |
| 2023 FY | 24.83 Billion INR | -28.74% |
| 2023 Q3 | - INR | -100.0% |
| 2023 Q2 | 29.56 Billion INR | 0.0% |
| 2023 Q4 | 24.83 Billion INR | 0.0% |
| 2023 Q1 | - INR | -100.0% |
| 2022 Q2 | 34.15 Billion INR | 0.0% |
| 2022 FY | 34.85 Billion INR | 28.69% |
| 2022 Q4 | 34.85 Billion INR | 0.0% |
| 2022 Q3 | - INR | -100.0% |
| 2022 Q1 | - INR | -100.0% |
| 2021 Q4 | 27.08 Billion INR | 0.0% |
| 2021 FY | 27.08 Billion INR | 36648.17% |
| 2020 FY | 73.7 Million INR | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Sun Pharmaceutical Industries Limited | 13.3 Million INR | -186648.12% |
| NATCO Pharma Limited | 53 Million INR | -46763.208% |
| Suven Pharmaceuticals Limited | 212.35 Million INR | -11596.161% |
| Syncom Formulations (India) Limited | -1.21 Million INR | 2037630.763% |
| Achyut Healthcare Limited | - INR | -Infinity% |
| Ajanta Pharma Limited | 235.2 Million INR | -10460.162% |
| Alkem Laboratories Limited | 400 Million INR | -6109.375% |
| Alpa Laboratories Limited | - INR | -Infinity% |
| Alembic Pharmaceuticals Limited | 628.8 Million INR | -3849.984% |
| AstraZeneca Pharma India Limited | 27.83 Million INR | -89127.978% |
| Aurobindo Pharma Limited | 21.34 Billion INR | -16.34% |
| Bajaj HealthCare Limited | 650.34 Million INR | -3719.127% |
| Bliss GVS Pharma Limited | 355.92 Million INR | -6878.355% |
| Brooks Laboratories Limited | 3.56 Million INR | -696604.067% |
| Divi's Laboratories Limited | 20 Million INR | -124087.5% |
| Dr. Reddy's Laboratories Limited | 5.99 Billion INR | -314.649% |
| Eris Lifesciences Limited | 6.54 Billion INR | -279.484% |
| FDC Limited | 2.46 Million INR | -1007097.891% |
| Glenmark Pharmaceuticals Limited | 1.51 Billion INR | -1537.375% |
| Glenmark Life Sciences Limited | 147.61 Million INR | -16726.435% |
| Granules India Limited | 689.71 Million INR | -3501.151% |
| Gufic Biosciences Limited | 1.53 Billion INR | -1513.211% |
| Hester Biosciences Limited | 1.81 Billion INR | -1266.402% |
| Indoco Remedies Limited | 3.51 Billion INR | -606.152% |
| Ind-Swift Laboratories Limited | 111.62 Million INR | -22150.641% |
| Ipca Laboratories Limited | 5.8 Billion INR | -327.93% |
| Jagsonpal Pharmaceuticals Limited | 75.57 Million INR | -32766.878% |
| Krebs Biochemicals & Industries Limited | 1.83 Billion INR | -1253.542% |
| Lasa Supergenerics Limited | - INR | -Infinity% |
| Laurus Labs Limited | 8.6 Billion INR | -188.677% |
| Lupin Limited | 1.55 Billion INR | -1499.53% |
| Mankind Pharma Limited | 248.67 Million INR | -9887.856% |
| Medicamen Biotech Limited | 12.55 Million INR | -197729.55% |
| Medico Remedies Limited | 8.67 Million INR | -286310.286% |
| Megasoft Limited | 1.35 Billion INR | -1730.231% |
| RPG Life Sciences Limited | -30.3 Million INR | 82071.947% |
| Sigachi Industries Limited | 265.79 Million INR | -9244.502% |
| Sun Pharma Advanced Research Company Limited | 106.6 Million INR | -23199.719% |
| Unichem Laboratories Limited | 382.22 Million INR | -6398.204% |
| Wanbury Limited | 820 Million INR | -2928.963% |
| Windlas Biotech Limited | 20.18 Million INR | -122979.782% |
| ZIM Laboratories Limited | 356 Million INR | -6876.708% |
| Zydus Lifesciences Limited | 251 Million INR | -9795.418% |
| Procter & Gamble Health Limited | 68.8 Million INR | -36001.017% |
| Amrutanjan Health Care Limited | 13.96 Million INR | -177717.153% |
| Bal Pharma Limited | 363.82 Million INR | -6726.79% |
| Strides Pharma Science Limited | 6.71 Billion INR | -269.881% |
| Venus Remedies Limited | 386.8 Million INR | -6321.277% |
| Aarti Pharmalabs Limited | 400 Thousand INR | -6209275.0% |
| Nectar Lifesciences Limited | 1.4 Billion INR | -1670.204% |
| Shilpa Medicare Limited | 5.6 Billion INR | -343.4% |
| Aarti Drugs Limited | 2.75 Billion INR | -802.099% |
| IOL Chemicals and Pharmaceuticals Limited | - INR | -Infinity% |
| Suven Life Sciences Limited | - INR | -Infinity% |
| Ind-Swift Limited | 10.09 Billion INR | -146.037% |
| Valiant Laboratories Limited | 746.63 Million INR | -3226.614% |
| J. B. Chemicals & Pharmaceuticals Limited | 236.4 Million INR | -10406.557% |
| Solara Active Pharma Sciences Limited | 1.05 Billion INR | -2246.924% |
| Themis Medicare Limited | 267.74 Million INR | -9176.724% |
| Hikal Limited | 4.22 Billion INR | -487.383% |
| Torrent Pharmaceuticals Limited | 16.04 Billion INR | -54.847% |
| Sequent Scientific Limited | 1.42 Billion INR | -1640.308% |
| Novartis India Limited | 50.7 Million INR | -48889.152% |
| Wockhardt Limited | 8.91 Billion INR | -178.76% |
| Jubilant Pharmova Limited | 31.67 Billion INR | 21.577% |
| Biofil Chemicals and Pharmaceuticals Limited | - INR | -Infinity% |
| Neuland Laboratories Limited | 449.2 Million INR | -5429.2% |
| Morepen Laboratories Limited | 33.64 Million INR | -73733.234% |
| Kilitch Drugs (India) Limited | - INR | -Infinity% |
| Mangalam Drugs & Organics Limited | 133.54 Million INR | -18499.157% |